Warning: The NCBI web site requires JavaScript to function. more...
Tumor-derived VEGF modulates hematopoiesis.
Xue Y, Chen F, Zhang D, Lim S, Cao Y.
J Angiogenes Res. 2009 Dec 23;1:9.
Related citations
Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG, Kim TD, Li G, Yoon WH, Chae CB.
Clin Cancer Res. 2005 Apr 1;11(7):2651-61.
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.
Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S.
Nat Med. 2001 Nov;7(11):1194-201.
Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S, Bayle M, Laïn G, Déléris G.
Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.
Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor.
Goi T, Fujioka M, Satoh Y, Tabata S, Koneri K, Nagano H, Hirono Y, Katayama K, Hirose K, Yamaguchi A.
Cancer Res. 2004 Mar 15;64(6):1906-10.
Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C.
Hum Pathol. 2003 Jan;34(1):18-27.
Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G, Clauss M, Risau W.
Dev Dyn. 1995 Nov;204(3):228-39.
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
Shibuya M.
J Biochem Mol Biol. 2006 Sep 30;39(5):469-78. Review.
Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model.
Lee SL, Rouhi P, Dahl Jensen L, Zhang D, Ji H, Hauptmann G, Ingham P, Cao Y.
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19485-90. Epub 2009 Nov 3.
VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP.
FASEB J. 2006 Jul;20(9):1495-7. Epub 2006 Jun 5.
VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.
Brekken RA, Thorpe PE.
J Control Release. 2001 Jul 6;74(1-3):173-81. Review.
Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancer.
Girling JE, Donoghue JF, Lederman FL, Cann LM, Achen MG, Stacker SA, Rogers PA.
Reprod Biol Endocrinol. 2010 Jul 8;8:84.
Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.
Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D, Fujise K, Liu M.
Cancer Res. 2009 Jan 15;69(2):518-25.
Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, Fleet C, Tritsaris K, Dissing S, Leboulch P, Cao Y.
Cancer Cell. 2002 Feb;1(1):99-108.
The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
Dineen SP, Sullivan LA, Beck AW, Miller AF, Carbon JG, Mamluk R, Wong H, Brekken RA.
BMC Cancer. 2008 Nov 27;8:352.
Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
Dikov MM, Oyama T, Cheng P, Takahashi T, Takahashi K, Sepetavec T, Edwards B, Adachi Y, Nadaf S, Daniel T, Gabrilovich DI, Carbone DP.
Cancer Res. 2001 Mar 1;61(5):2015-21.
Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S.
Int J Cancer. 2007 Nov 15;121(10):2181-91.
[A novel model for visualization of tumor cell-induced angiogenesis in vivo].
Li L, Xu P, Hu HH, Liu WW, Yi MY, Li CY, Huang Q.
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Jan;34(1):21-7. Chinese.
Tumor Growth: A Putative Role for Platelets?
Verheul HM, Pinedo HM.
Oncologist. 1998;3(2):II.
Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY.
Hepatobiliary Pancreat Dis Int. 2005 May;4(2):220-6.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on